CMS Urged To Lift All Evidence-Development Restrictions On PET For Solid Tumors
This article was originally published in The Gray Sheet
Executive Summary
Move to lift coverage-with-evidence-development restrictions is widely supported by industry, medical specialty societies and clinicians.